1. The crystal structure of ESBL TLA-1 in complex with clavulanic acid reveals a second acylation site
- Author
-
Enrique Rudiño-Piñera, Claudia Rodríguez-Almazán, Jesús Silva-Sánchez, and Víctor Cifuentes-Castro
- Subjects
Models, Molecular ,0301 basic medicine ,Stereochemistry ,Acylation ,Static Electricity ,Mutant ,Biophysics ,Context (language use) ,Crystallography, X-Ray ,Ligands ,medicine.disease_cause ,Biochemistry ,beta-Lactamases ,03 medical and health sciences ,0302 clinical medicine ,Clavulanic acid ,Hydrolase ,medicine ,Molecular Biology ,Escherichia coli ,Clavulanic Acid ,chemistry.chemical_classification ,biology ,Cell Biology ,biology.organism_classification ,030104 developmental biology ,Enzyme ,chemistry ,030220 oncology & carcinogenesis ,Mutation ,Mutant Proteins ,Enterobacter cloacae ,medicine.drug - Abstract
β-lactamases are the main molecules responsible for giving bacterial resistance against β-lactam antibiotics. The study of β-lactamases has allowed the development of antibiotics capable of inhibiting these enzymes. In this context, extended spectrum β-lactamase (ESBL) TLA-1 has spread in Escherichia coli and Enterobacter cloacae clinical isolates during the last 30 years in Mexico. In this research, the 3D structures of ESBL TLA-1 and TLA-1 S70G mutant, both ligand-free and in complex with clavulanic acid were determined by X-ray crystallography. Four clavulanic acid molecules were found in the structure of TLA-1, two of those were intermediaries of the acylation process and were localized covalently bound to two different amino acid residues, Ser70 and Ser237. The coordinates of TLA-1 in complex with clavulanic acid shows the existence of a second acylation site, additional to Ser70, which might be extendable to several members of the subclass A β-lactamases family. This is the first time that two serines involved in binding clavulanic acid has been reported and described to an atomic level.
- Published
- 2020
- Full Text
- View/download PDF